2. Academic Validation
  3. Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab

Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab

  • Allergy. 2020 Apr;75(4):940-942. doi: 10.1111/all.14035.
Luis A Pérez de Llano 1,  David Dacal Rivas 1,  Borja G Cosío 2 3
Affiliations

Affiliations

  • 1 Pneumology Service, Hospital Universitario Lucus Agusti, EOXI Lugo, Cervo, Monforte, Spain.
  • 2 Department of Respiratory Medicine, Hospital Universitario Son Espases-IdISBa, Palma de Mallorca, Mallorca, Spain.
  • 3 CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
PMID: 31483864 DOI: 10.1111/all.14035
Figures
Products